AngioScore Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AngioScore's estimated annual revenue is currently $17.1M per year.(i)
  • AngioScore's estimated revenue per employee is $251,000

Employee Data

  • AngioScore has 68 Employees.(i)
  • AngioScore grew their employee count by -4% last year.

AngioScore's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is AngioScore?

The AngioSculpt Scoring Balloon Catheter significantly alters the landscape for treating both peripheral arterial disease (PAD) and coronary artery disease (CAD). The innovative nitinol scoring element scores the plaque circumferentially, providing a precise and predictable dilatation across a wide range of lesion types. AngioSculpt provides the versatility and effectiveness of a new technology together with the simplicity and deliverability of a high-performance balloon catheter.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$17.1M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AngioScore News

2022-04-19 - Peripheral Intervention Devices Consumption Market Size, Share ...

... Market Size, Share, Outlook And Forecast 2022-2030| Key Players – Abbott Vascular, Angioscore Ltd., Cordis Corp., Boston Scientific.

2022-04-19 - Peripheral Intervention Devices Consumption Market Size, Share ...

... Market Size, Share, Outlook And Forecast 2022-2030| Key Players – Abbott Vascular, Angioscore Ltd., Cordis Corp., Boston Scientific.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.5M683%N/A
#2
$8.9M688%N/A
#3
$15M688%N/A
#4
$17.3M7017%N/A
#5
$25.2M70-1%N/A